| Revenues | 977,716a | 831,103a | 627,623a |
| Transaction costs | -152,106a | -122,291a | -110,165a |
| Other operating expenses | -169,550a | -160,609a | -149,199a |
| Research and development expenses | -134,631a | -119,197a | -115,041a |
| Sales and marketing expenses | -211,839a | -196,654a | -164,564a |
| General and administrative expenses | -113,263a | -100,929a | -90,010a |
| Depreciation and amortization | -47,296a | -27,814a | -20,858a |
| Total operating expenses | -828,685a | -727,494a | -649,837a |
| Operating income (loss) | 149,031a | 103,609a | -22,214a |
| Financial income (expense) | — | — | — |
| Gain from change in fair value of warrants | 2,767a | 17,359a | 33,963a |
| Loss on warrant repurchase/redemption | -14,746a | 0a | 0a |
| Other financial income (expense), net | 2,419a | 11,568a | -10,131a |
| Financial income (expense), net | -9,560a | 28,927a | 23,832a |
| Income before income taxes and share in losses of associated company | 139,471a | 132,536a | 1,618a |
| Income taxes | -18,308a | -39,203a | -13,586a |
| Share in losses of associated company | 0a | 0a | -2a |
| Net income (loss) | 121,163a | 93,333a | -11,970a |